Current Global Status and Impact of Human Papillomavirus Vaccination: Implications for India
This article, published in the Indian Journal of Medical Research, discusses the efficacy and safety of human papillomavirus (HPV) vaccines, the current status of their introduction in National Immunization Programmes (NIPs), and the relevance of this information to India, which contributes a fifth of the global burden of cervical cancer. The authors report that HPV vaccines are well-tolerated, and introduction of HPV vaccines in the NIPs of low- and middle-income countries significantly reduced frequency of HPV 16 and 18 infections, genital warts, and cervical premalignant lesions in vaccinated cohorts. They conclude that the high burden of cervical cancer and the high efficacy and safety of HPV vaccines justify introduction in the Indian NIP as soon as possible.
Author: Sankaranarayanan R, Bhatla N, Basu P
» Visit web page (English)
(Located at www.ijmr.org.in)
Citation: Sankaranarayanan R, Bhatla N, Basu P. Current Global Status and Impact of Human Papillomavirus Vaccination: Implications for India. Indian Journal of Medical Research. 2016;144(2):169-180.
Resource types: Peer-reviewed journal
Diseases/vaccines: Human papillomavirus (HPV)